Synonyms: | |
Status: | Phase 2 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
UNII: | V71TF6V9M7 |
InChI Key | KPBNHDGDUADAGP-VAWYXSNFSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C24H29N3O2 |
Molecular Weight | 391.52 |
AlogP | 3.93 |
Hydrogen Bond Acceptor | 3.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 8.0 |
Polar Surface Area | 62.3 |
Molecular species | NEUTRAL |
Aromatic Rings | 2.0 |
Heavy Atoms | 29.0 |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | Nicotinamide phosphoribosyltransferase inhibitor | PubMed |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2C
Cytochrome P450 2C9
|
- | 3600 | - | - | - | |
Enzyme
Cytochrome P450
Cytochrome P450 family 3
Cytochrome P450 family 3A
Cytochrome P450 3A4
|
- | 540-1500 | - | - | - | |
Enzyme
|
- | 0-14800 | - | 0-6 | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Melanoma | 2 | D008545 | ClinicalTrials |
Lymphoma, T-Cell, Cutaneous | 2 | D016410 | ClinicalTrials |
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | D015451 | ClinicalTrials |
Resources | Reference |
---|---|
ChEMBL | CHEMBL566757 |
DrugBank | DB12731 |
FDA SRS | V71TF6V9M7 |
Guide to Pharmacology | 7745 |
PDB | DGB |
PubChem | 6914657 |
SureChEMBL | SCHEMBL82368 |
ZINC | ZINC000003828115 |